膀胱がん治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR0872)
◆英語タイトル:Global Bladder Cancer Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR0872
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、膀胱がん治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(移行上皮がん、浸潤性膀胱がん、表在性膀胱がん、扁平上皮がん、その他)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・膀胱がん治療の市場動向
・企業の競争状況、市場シェア
・膀胱がん治療の種類別市場規模(移行上皮がん、浸潤性膀胱がん、表在性膀胱がん、扁平上皮がん、その他)
・膀胱がん治療の用途別市場規模(病院、クリニック、その他)
・膀胱がん治療の北米市場規模2016-2027(アメリカ、カナダ)
・膀胱がん治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・膀胱がん治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・膀胱がん治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・膀胱がん治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bristol-Myers Squibb、Eli Lilly、F. Hoffman-La Roche、Pfizer)
・結論
【レポートの概要】

The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost layer called urothelium or transitional epithelium, composed of epithelium or transitional cells.
The availability of targeted therapy will be one of the major factors driving the growth prospects for the market until the end of 2021. The advancements in drug targeting techniques have enabled doctors to administer drugs directly into the bladder having tumors. This in turn, will help in avoiding side effects of these drugs on healthy cells. With a better understanding of tumor immunology scientists can also now develop new drugs targeted at cancer cells. TECENTRIQ and OPDIVO are the PD-L1 inhibitors recently approved by the US FDA for the treatment of urothelial carcinoma. One of the effective procedures for the diagnosis of bladder cancer, cystoscopy, involves the use of a long thin tube called cystoscope. This helps the urologist to extract a small piece of the abnormal tissue and send it to the pathologists for examination. With the emergence of effective diagnostic tools such as flexible cystoscope, urologists will prefer cystoscopy since it can be easily performed in the outpatient department. This emergence of effective diagnostic tools will be one of the major trends that will gain traction in the bladder cancer therapeutics market during the next four years.

Market Analysis and Insights: Global Bladder Cancer Therapeutics Market
The global Bladder Cancer Therapeutics market size is projected to reach US$ 3988.6 million by 2026, from US$ 3147.5 million in 2019, at a CAGR of 3.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bladder Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bladder Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bladder Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bladder Cancer Therapeutics market.

Global Bladder Cancer Therapeutics Scope and Market Size
Bladder Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bladder Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Transitional Cell Bladder Cancer
Invasive Bladder Cancer
Superficial Bladder Cancer
Squamous Cell Bladder Cancer
Others

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb
Eli Lilly
F. Hoffman-La Roche

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bladder Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transitional Cell Bladder Cancer
1.2.3 Invasive Bladder Cancer
1.2.4 Superficial Bladder Cancer
1.2.5 Squamous Cell Bladder Cancer
1.2.6 Others
1.3 Market by Application
1.3.1 Global Bladder Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bladder Cancer Therapeutics Market Perspective (2016-2027)
2.2 Bladder Cancer Therapeutics Growth Trends by Regions
2.2.1 Bladder Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bladder Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Bladder Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Bladder Cancer Therapeutics Industry Dynamic
2.3.1 Bladder Cancer Therapeutics Market Trends
2.3.2 Bladder Cancer Therapeutics Market Drivers
2.3.3 Bladder Cancer Therapeutics Market Challenges
2.3.4 Bladder Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bladder Cancer Therapeutics Players by Revenue
3.1.1 Global Top Bladder Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Bladder Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Bladder Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bladder Cancer Therapeutics Revenue
3.4 Global Bladder Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Bladder Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bladder Cancer Therapeutics Revenue in 2020
3.5 Bladder Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Bladder Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Bladder Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bladder Cancer Therapeutics Breakdown Data by Type
4.1 Global Bladder Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Bladder Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Bladder Cancer Therapeutics Breakdown Data by Application
5.1 Global Bladder Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Bladder Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bladder Cancer Therapeutics Market Size (2016-2027)
6.2 North America Bladder Cancer Therapeutics Market Size by Type
6.2.1 North America Bladder Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Bladder Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Bladder Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Bladder Cancer Therapeutics Market Size by Application
6.3.1 North America Bladder Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Bladder Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Bladder Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Bladder Cancer Therapeutics Market Size by Country
6.4.1 North America Bladder Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Bladder Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bladder Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Bladder Cancer Therapeutics Market Size by Type
7.2.1 Europe Bladder Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Bladder Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Bladder Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Bladder Cancer Therapeutics Market Size by Application
7.3.1 Europe Bladder Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Bladder Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Bladder Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Bladder Cancer Therapeutics Market Size by Country
7.4.1 Europe Bladder Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Bladder Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bladder Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Bladder Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Bladder Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bladder Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bladder Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bladder Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Bladder Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bladder Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bladder Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bladder Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Bladder Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bladder Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bladder Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Bladder Cancer Therapeutics Market Size by Type
9.2.1 Latin America Bladder Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Bladder Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Bladder Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Bladder Cancer Therapeutics Market Size by Application
9.3.1 Latin America Bladder Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Bladder Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Bladder Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Bladder Cancer Therapeutics Market Size by Country
9.4.1 Latin America Bladder Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Bladder Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bladder Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bladder Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Bladder Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Bladder Cancer Therapeutics Introduction
11.1.4 Bristol-Myers Squibb Revenue in Bladder Cancer Therapeutics Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Bladder Cancer Therapeutics Introduction
11.2.4 Eli Lilly Revenue in Bladder Cancer Therapeutics Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 F. Hoffman-La Roche
11.3.1 F. Hoffman-La Roche Company Details
11.3.2 F. Hoffman-La Roche Business Overview
11.3.3 F. Hoffman-La Roche Bladder Cancer Therapeutics Introduction
11.3.4 F. Hoffman-La Roche Revenue in Bladder Cancer Therapeutics Business (2016-2021)
11.3.5 F. Hoffman-La Roche Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bladder Cancer Therapeutics Introduction
11.4.4 Pfizer Revenue in Bladder Cancer Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 膀胱がん治療の世界市場規模・現状・予測2021年-2027年(Global Bladder Cancer Therapeutics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。